# HIKMA PHARMACEUTICALS USA INC. – FDA Inspection, Jul 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/hikma-pharmaceuticals-usa-inc/2b9bbcb5-0b56-44ed-b708-f3cbbd8a563e
Source feed: FDA_Inspections

> FDA inspection 1286008 of HIKMA PHARMACEUTICALS USA INC., July 13, 2026. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286008
- Company Name: HIKMA PHARMACEUTICALS USA INC.
- Inspection Date: 2026-07-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jay-b-shah/c437fff9-807e-4dea-80c0-8f77850db6f8)

Company: https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/5c9e9af8-ac92-437a-a08c-f2b41660f1b0

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248